SCHEMBL24256124

SCHEMBL24256124

CC1(C)O[C@@H]2[C@H](N)[C@@H](O)O[C@](C)(CO)[C@@H]2O1

nearest known ligand 0.30

Predicted protein targets (top 1)

geneUniProtsupporting neighboursconfidence
▸ GLB1 P16278 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL18722896 0.72 ASGR1 (0.40) —
SCHEMBL21694344 0.70 — —
SCHEMBL18723082 0.68 CA2 (0.35) —
SCHEMBL12449344 0.67 GLB1 (0.33) GLB1
SCHEMBL24256838 0.63 CA2 (0.33) GLB1
SCHEMBL14853747 0.63 GLB1 (0.40) GLB1
SCHEMBL16063073 0.63 GLB1 (0.40) GLB1
SCHEMBL6881792 0.61 GLB1 (0.30) GLB1
SCHEMBL14709166 0.61 GBA1 (0.35) —
SCHEMBL7622682 0.61 GAA (0.36) —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2022035997-A1 IN VIVO ASSEMBLY OF ASGPR BINDING THERAPEUTICS AVILAR THERAPEUTICS, INC. (US) 2022-02-17 — — WO disclosed
Send feedback